Home ⟩ Insights

Insights

fda

3 min read • September 20, 2022

FDA Says No Way To Food Companies Wanting To Get On The CBD Gravy Train

1 min read • September 16, 2022

India Globalization Capita Just Got FDA Approval To Start Enrolling Their Phase 2 Alzheimer Trial With IGC-AD1, A Cannabis Drug

4 min read • September 7, 2022

E-Cigarette Maker To Pay Over $430M To Settle Multi-State Vaping Inquiry, Cannabis Investors Need To Pay Attention

3 min read • August 24, 2022

Taking Care Of Cannabis Consumers, Federal Trade Commission Issues Refunds To CBD Buyers, Here’s Why

2 min read • August 1, 2022

Senate Marijuana & Psychedelics Reforms: Appropriations Committee Chair Patrick Leahy Marks 12 Bills For FY 2023

3 min read • July 25, 2022

Congress: Two New Bills Would Pressure The DEA To Allow Patient Access To Psychedelics And Marijuana

3 min read • July 14, 2022

As Cannabis Industry Grows, So Do Court Cases And Litigation, Here’s A Look At Emerging Trends

2 min read • July 14, 2022

FDA Impact On CBD Market: With Federal Regulation, CBD Sales Would Hit $11B By 2027, Without It? $4.5B Less

2 min read • July 5, 2022

What Is The Role Of The FDA In Measures Taken By Hawaii Officials Against A CBD Company?

4 min read • June 23, 2022

Congress Urges USDA & FDA To Resolve ‘Hot’ Hemp Difficulties, Addresses CBD Advertising, Veterans & Cannabis Research, Psychedelics

2 min read • June 16, 2022

Johnson & Johnson Urges FDA To Take Interim Steps As It Continues To Review CBD

5 min read • June 15, 2022

Cannabis Reg. Update: FDA To Review CBD Again, DEA Wins In Hemp Extract Case & More

Latest Headlines

2 min read • June 2, 2026

Vireo Growth Reshapes Share Structure After Major Expansion Transactions

2 min read • June 2, 2026

Cannabis Giant, Verano, Joins Industry Peers In Reverse Stock Split Trend With 1-For-5 Consolidation

7 min read • June 2, 2026

Cannabis M&A Is Back, But Not The Way Investors Expected

4 min read • June 2, 2026

EXCLUSIVE: Virginia Governor Defends Cannabis Veto, Citing Timeline And Licensing Concerns

2 min read • June 1, 2026

Five-Month Hemp Enforcement Grace Period Ends In Oregon, Here’s What Businesses Must Know

3 min read • June 1, 2026

New Tennessee Hemp Rules Threaten THCa Market And Millions Of Dollars In Sales

3 min read • June 1, 2026

Robinhood Opens The Door To U.S. Cannabis Stocks

4 min read • June 1, 2026

Fireman Entrepreneur Award Builds Momentum Ahead of 2026 Announcement in Chicago

4 min read • June 1, 2026

Thin Legal Challenge from State AGs Could Still Complicate Federal Cannabis Rescheduling Effort

2 min read • May 29, 2026

Canopy Growth Bets On Europe As It Relaunches This Legacy Brand in Germany’s $1B Medical Cannabis Market

2 min read • May 29, 2026

Minnesota’s New Cannabis Bill Reshapes Market For Medical And Rec Operators

2 min read • May 28, 2026

New Study Tracks How Cannabis Beverages Are Replacing Alcohol In Everyday Settings

Browse By Channels

After-Hours Center

Analyst Ratings

Be Your Own Boss

Broad U.S. Equity ETFs

california cannabis

cannabis earnings

Christopher Dillis

Congress cannabis

Earnings Misses

Emerging Market ETFs

Emerging Markets

Entrepreneurship

Federal Reserve

Financial Advisors

first quarter earnings

hemp legalization

hemp regulation

illegal cannabis farms

intoxicating hemp-derived products

Intraday Update

Macro Economic Events

Macro Notification

Market-Moving Exclusives

Movers & Shakers

Personal Finance

Pre-Market Outlook

Small Cap Analysis

Success Stories

UC Berkeley Cannabis Research Center

unlicensed cannabis

Join the Cannabis Revolution

Ready to access the most aggressive cannabis intelligence platform? Get started with IGNITE IT today.